CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- S-1/A Offering Registration Statement
- CERT Other Certification
- 8-A12B Other Registration of Securities
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
Page 20 of 20 · 400 filings